Literature DB >> 17726663

Radioimmunoguided surgery (RIGS), PET/CT image-guided surgery, and fluorescence image-guided surgery: past, present, and future.

Duxin Sun1, Mark Bloomston, George Hinkle, Osama Habib Al-Saif, Nathan C Hall, Stephen P Povoski, Mark W Arnold, Edward W Martin.   

Abstract

(125)I-labeled anti-TAG-72 antibodies were applied in radioimmunoguided surgery (RIGS) to remove gross and occult tumors. It is challenging to handle (125)I-labeled materials. PET/CT image-guided surgery utilizes (18)FDG to monitor the biochemical activity of the tumor and to integrate pre- and postoperative imaging for complete tumor removal. PET/CT image-guided surgery only detects later stage disease. Fluorescence image-guided surgery using anti-TAG-72 antibodies may provide opportunities for intraoperative cancer detection of both gross and occult tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17726663     DOI: 10.1002/jso.20869

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  19 in total

1.  Comprehensive evaluation of occupational radiation exposure to intraoperative and perioperative personnel from 18F-FDG radioguided surgical procedures.

Authors:  Stephen P Povoski; Ismet Sarikaya; William C White; Steven G Marsh; Nathan C Hall; George H Hinkle; Edward W Martin; Michael V Knopp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07-10       Impact factor: 9.236

2.  Site specific discrete PEGylation of (124)I-labeled mCC49 Fab' fragments improves tumor MicroPET/CT imaging in mice.

Authors:  Haiming Ding; Michelle M Carlton; Stephen P Povoski; Keisha Milum; Krishan Kumar; Shankaran Kothandaraman; George H Hinkle; David Colcher; Rich Brody; Paul D Davis; Alex Pokora; Mitchell Phelps; Edward W Martin; Michael F Tweedle
Journal:  Bioconjug Chem       Date:  2013-10-31       Impact factor: 4.774

3.  A 3E8.scFv.Cys-IR800 Conjugate Targeting TAG-72 in an Orthotopic Colorectal Cancer Model.

Authors:  Li Gong; Haiming Ding; Nicholas E Long; Brandon J Sullivan; Edward W Martin; Thomas J Magliery; Michael F Tweedle
Journal:  Mol Imaging Biol       Date:  2018-02       Impact factor: 3.488

Review 4.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

5.  Biodistribution of HuCC49DeltaCH2-beta-galactosidase in colorectal cancer xenograft model.

Authors:  Yanke Yu; Lanyan Fang; Duxin Sun
Journal:  Int J Pharm       Date:  2009-11-26       Impact factor: 5.875

6.  Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice.

Authors:  Peng Zou; Songbo Xu; Stephen P Povoski; Anna Wang; Morgan A Johnson; Edward W Martin; Vish Subramaniam; Ronald Xu; Duxin Sun
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

7.  124I-HuCC49deltaCH2 for TAG-72 antigen-directed positron emission tomography (PET) imaging of LS174T colon adenocarcinoma tumor implants in xenograft mice: preliminary results.

Authors:  Peng Zou; Stephen P Povoski; Nathan C Hall; Michelle M Carlton; George H Hinkle; Ronald X Xu; Cathy M Mojzisik; Morgan A Johnson; Michael V Knopp; Edward W Martin; Duxin Sun
Journal:  World J Surg Oncol       Date:  2010-08-06       Impact factor: 2.754

8.  Multimodal imaging and detection approach to 18F-FDG-directed surgery for patients with known or suspected malignancies: a comprehensive description of the specific methodology utilized in a single-institution cumulative retrospective experience.

Authors:  Stephen P Povoski; Nathan C Hall; Douglas A Murrey; Andrew Z Chow; Jay R Gaglani; Eamonn E Bahnson; Cathy M Mojzisik; Maureen P Kuhrt; Charles L Hitchcock; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2011-11-23       Impact factor: 2.754

9.  Intraoperative detection of ¹⁸F-FDG-avid tissue sites using the increased probe counting efficiency of the K-alpha probe design and variance-based statistical analysis with the three-sigma criteria.

Authors:  Stephen P Povoski; Gregg J Chapman; Douglas A Murrey; Robert Lee; Edward W Martin; Nathan C Hall
Journal:  BMC Cancer       Date:  2013-03-04       Impact factor: 4.430

10.  Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting.

Authors:  J P Tiernan; S L Perry; E T Verghese; N P West; S Yeluri; D G Jayne; T A Hughes
Journal:  Br J Cancer       Date:  2013-01-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.